IDEAYA Biosciences, Inc. Common Stock
IDYA
$28.07
-10.83%
IDYA
IDEAYA Biosciences, Inc. Common Stock
$28.07
IDYA price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IDEAYA Biosciences, Inc. Common Stock's 12-month outlook, with a consensus price target around $36.49 and implied upside of +30.0% versus the current price.
Average Target
$36.49
13 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
13
covering this stock
Price Range
$22 - $36
Analyst target range
IDYA Technical Analysis
Beta
-0.05
-0.05x market volatility
Max Drawdown
-26.4%
Largest decline past year
52-Week Range
$21-$39
Price range past year
Annual Return
+29.3%
Cumulative gain past year
| Period | IDYA Return | S&P 500 |
|---|---|---|
| 1m | -0.9% | -0.1% |
| 3m | -17.6% | +9.0% |
| 6m | -16.4% | +7.0% |
| 1y | +29.3% | +22.9% |
| ytd | -17.1% | +8.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is IDYA Overvalued?
PE
-26.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-19.2x
Enterprise Value Multiple
